Previous 10 | Next 10 |
InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...
NEW YORK, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire is investigating certain officers and directors of Lannett Company, Inc. (NYSE: LCI), Molson Coors Brewing Company (NYSE: TAP), AxoGen, Inc. (NASDAQ: AXGN), and American Renal Associates Holdings, Inc. (NYSE: ARA) on beha...
Humanity has advanced, when it has advanced, not because it has been sober, responsible, and cautious, but because it has been playful, rebellious, and immature ." - Tom Robbins Even with the recent volatility and declines in the markets, the S&P 500 is only down some five percent fro...
Gainers: Cambrex Corporation (NYSE: CBM ) +47% . Weight Watchers International (NASDAQ: WW ) +40% . Paratek Pharmaceuticals (NASDAQ: PRTK ) +35% . Owens & Minor (NYSE: OMI ) +29% . Match Group (NASDAQ: MTCH ) +27% . SolarEdge Technologies (NASDAQ: SEDG ) +24% . Guardant Hea...
Neurocrine Biosciences (NASDAQ: NBIX ) initiated with Outperform rating and $118 (24% upside) price target at RBC. More news on: Neurocrine Biosciences, Inc., Regeneron Pharmaceuticals, Inc., Allergan plc, Healthcare stocks news, Stocks on the move, , Read more ...
AxoGen, Inc. (AXGN) Q2 2019 Earnings Conference Call August 06, 2019, 04:30 PM ET Company Participants Kaila Krum - Vice President of Investor Relations and Corporate Development Karen Zaderej - Chairman, Chief Executive Officer, and President Peter Mariani - Chief Financial Offi...
AxoGen (NASDAQ: AXGN ): Q2 Non-GAAP EPS of -$0.10 beats by $0.09 ; GAAP EPS of -$0.18 beats by $0.01 . More news on: AxoGen, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
ALACHUA, Fla., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today reported financial results and business highlights for the second quarter ended June ...
Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you c...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , iTunes...
News, Short Squeeze, Breakout and More Instantly...
ALACHUA and TAMPA, Fla., July 23, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that it will report second quarter 2024 financial results on Thursday, August 8, 2024, b...
2024-07-01 07:30:05 ET Raymond James analyst issues OUTPERFORM recommendation for AXGN on July 1, 2024 05:51AM ET. AXGN was trading at $7.24 at issue of the analyst recommendation. Historical Analyst Recommendations Latest 10 recommendations
ALACHUA, Fla. and TAMPA, Fla., July 01, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announced making an inducement grant on July 1, 2024, under NASDAQ listing rule 5635(c)(4) in conn...